Updates are available Correction dated 2024-01-29
Click to view Correction: https://doi.org/10.1038/s41598-024-52791-0
-
Authors
Gebremedhin, Amanuel Tesfay
Hogan, Alexandra B.
Blyth, Christopher C.
Glass, Kathryn
Moore, Hannah C.
-
Funding
Funding for this research was provided by:
Wesfarmers Centre of Vaccines and Infectious Diseases
Imperial College Research Fellowship
MRC Centre for Global Infectious Disease Analysis (reference MR/R015600/1)
National Health and Medical Research Council (1045668)
- License Information
-
More Information
Article History
Received: 3 April 2021
Accepted: 14 December 2021
First Online: 10 January 2022
Change Date: 29 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-024-52791-0
Competing interests
: ABH declares personal fees from the World Health Organization, outside the submitted work. ABH was previously engaged by Pfizer Inc to advise on modelling RSV vaccination strategies for which she received no financial compensation. The remaining authors have no conflicts of interest.
